Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1/2 1

Status

Unknown 5

Sponsor Class

OTHER 5NIH 5NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 28Breast 26CNS 22Genitourinary 11Sarcoma 10Gynecologic 8Thoracic 7Head & Neck 5Dermatologic 5Other solid neoplasm 2Lymphoid 1

Conditions

Melanoma 4Uveal Melanoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

aldesleukin 69Cyclophosphamide 50fludarabine phosphate 36fludarabine 30Interleukin-2 27incomplete Freund's adjuvant 22Ipilimumab 20Biopsy 20Specimen Handling 19Magnetic Resonance Spectroscopy 19MART-1 Antigen 15CTLA-4 Antigen 15sargramostim 14Nivolumab 13Filgrastim 13montanide ISA 51 12Sorafenib 12Interferon-alpha 11pembrolizumab 10trametinib 9Temozolomide 9Bevacizumab 9dabrafenib 8temsirolimus 7Sirolimus 7Gene Expression Profiling 7tanespimycin 6Paclitaxel 6Dacarbazine 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NIH × Chemotherapy, Adjuvant × Dermatologic × Clear all
NCT00489944 2014-01-10

Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

National Cancer Institute (NCI)

Phase 2 Unknown
50 enrolled
Dermatologic

Uveal Melanoma

NCT00492505 2014-01-10

Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma

National Cancer Institute (NCI)

Phase 2 Unknown
200 enrolled
Dermatologic

Melanoma

NCT01082198 2013-08-26

Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes

National Cancer Institute (NCI)

Phase 1/2 Unknown
22 enrolled
Dermatologic

Melanoma

NCT00002455 2013-08-07

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma

National Cancer Institute (NCI)

Phase 3 Unknown
BreastDermatologicGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Melanoma, Colorectal Neoplasms

NCT00005052 2009-02-09

Vaccine Therapy in Treating Patients With Primary Stage II Melanoma

National Cancer Institute (NCI)

Phase 3 Unknown
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡